brain tumor treatment

SHANGHAI, China, May 29, 2026 Dizal has announced groundbreaking results from the global Phase 3 WU-KONG28 trial, demonstrating that...

BOSTON, Massachusetts, May 31, 2026 Servier has announced extended follow-up results from the pivotal Phase 3 INDIGO trial, demonstrating...

Paris, France – April 22, 2026 In a major breakthrough for pediatric oncology, Ipsen has announced that the European...